European Journal of Dermatology
MENUTreatment of recalcitrant erythrodermic psoriasis with ustekinumab Volume 24, issue 3, May-June 2014
Tables
1 Institute of Dermatology,
Ospedale “San Michele”.
Piazza Rodolone, 1
33013-Gemona del Friuli (Udine), Italy
Ospedale “San Michele”.
Piazza Rodolone, 1
33013-Gemona del Friuli (Udine), Italy
- DOI : 10.1684/ejd.2014.2325
- Page(s) : 387-90
- Published in: 2014
Erythrodermic psoriasis (EP) can be challenging to treat since several factors, such as failure or intolerance, limit favourable outcomes with traditional therapies [1]. The conventional treatments recommended for EP are methotrexate, oral retinoids and cyclosporine [2], although systemic steroids are still used, especially in severe and unstable forms, since they usually induce a rapid clinical improvement [2, 3]. Recently, some cases of EP have been successfully treated with biological agents, [...]